Search results
Author(s):
Renzo Laborante
,
Attilio Restivo
,
Daniela Mele
,
et al
Added:
1 week ago
Background of Heart Failure
Author(s):
Raluca Ibănescu
,
Diana-Alexandra Mîțu
,
Iacob-Daniel Goje
,
et al
Added:
1 month ago
Article
Author(s):
Stephen J Greene
Added:
4 days ago
ESC HF 25 - VELOCITY shows bypassing an initiation dose of 2.5mg, and and beginning with 5mg vericiguat safe and tolerable in 9/10 patients with heart failure with ejection fraction <45%.Prof Stephen Greene (Duke Clinical Research Institute, US) discusses the findings from VELOCITY (NCT06195930; Bayer), a phase 2b open-label clinical study evaluating the tolerability and safety of an…
View more
Author(s):
Karol Mirkowski
,
Ercole Vellone
,
Bernadetta Żółkowska
,
et al
Added:
2 months ago
Author(s):
Antonio Luca Maria Parlati
,
Cristina Madaudo
,
Vincenzo Nuzzi
,
et al
Added:
3 months ago
Author(s):
Silvana Di Maio
,
Ritu Thamman
,
Julia Grapsa
Added:
6 months ago
Author(s):
Fraser J Graham
,
Antonio Iaconelli
,
Piotr Sonecki
,
et al
Added:
1 year ago
Congestion in Heart Failure
Author(s):
Marko Kumric
,
Tina Ticinovic Kurir
,
Josko Bozic
,
et al
Added:
8 months ago
Article
Author(s):
Ruth Masterson Creber
Added:
1 month ago
ACC 25 - Findings of the MIGHTy-Heart study shows no difference between mobile integrated healthcare and a traditional transitions of care coordinator approach in 30-day all-cause readmissions or health status.Dr Ruth Masterson Creber (Columbia University, New York, US) joins us onsite at ACC to discuss the findings from MIGHTy-Heart, a comparative effectiveness study that evaluated two different…
View more
Author(s):
C Noah Nilsson
,
Mads Kristian Ersbøll
,
Finn Gustafsson
Added:
8 months ago